First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
Maria M E JongsmaMartine A AardoomMartinus A CozijnsenMerel van PietersonTim de MeijMichael GroenewegObbe F NorbruisVictorien M WoltersHerbert M van WeringIva HojsakKaija-Leena KolhoThalia HummelJanneke StapelbroekCathelijne van der FeenPatrick F van RheenenMichiel P van WijkSarah T A Teklenburg-RoordMarco W J SchreursDimitris RizopoulosMichail DoukasJohanna C EscherJanneke N SamsomLissy de RidderPublished in: Gut (2020)
ClinicalTrials.gov Registry (NCT02517684).